E Fund Management Co., Ltd. Sorrento Therapeutics, Inc. Transaction History

E Fund Management Co., Ltd.

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	BUY	$0.74 - $1.83 $16,885 - $41,756	22,818 Added 11.35%	223,808 $198,000
Q3 2022 Nov 14, 2022	BUY	$1.51 - $2.88 $7,122 - $13,584	4,717 Added 2.4%	200,990 $316,000
Q2 2022 Aug 15, 2022	BUY	$1.24 - $2.33 $90,799 - $170,614	73,225 Added 59.51%	196,273 $395,000
Q1 2022 May 12, 2022	BUY	$2.0 - $4.9 $190,432 - $466,558	95,216 Added 342.11%	123,048 $287,000
Q4 2021 Feb 11, 2022	BUY	$4.65 - $7.23 $28,216 - $43,871	6,068 Added 27.88%	27,832 $129,000
Q3 2021 Nov 12, 2021	BUY	$7.41 - $10.99 $61,028 - $90,513	8,236 Added 60.88%	21,764 $166,000
Q1 2021 May 12, 2021	BUY	$7.03 - $16.51 $95,101 - $223,347	13,528 New	13,528 $111,000

5.47M

Ticker SRNE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 449,952,000
Market Cap $148M
Description
Sorrento Therapeutics, Inc., a clinical stage and commercial biopharmaceutical company, develops therapies for cancer, autoimmune, inflammatory, viral, and neurodegenerative diseases. It operates through two segments, Sorrento Therapeutics and Scilex. The company provides cancer therapeutic by leveraging its proprietary G-MAB antibody library an...

Get notified when there are updates to the investment portfolio of E Fund Management Co., Ltd., based on Form 13F filings with the SEC.

Stay updated on E Fund Management Co., Ltd. with notifications on news.